Champions Oncology, Inc. Q2 FY2026 Earnings Call

Champions Oncology, Inc. (CSBR)

Earnings Call FY2026 Q2 Call date: 2025-12-15 Concluded

Quarter scorecard

Revenue

$15.04M

+11.5% YoY

Diluted EPS

$0.02

-60% YoY

Net income

$268,000

-63.2% YoY

Pharmacology Services $14.52M

+16.1%

Product And Service Other $363,000

-63.4%

Translational Oncology Solutions TOS License Revenue $157,000